Cannabis Law Report

MARCH 29, 2020

This “zero recall” standard, the team said, was attributed to the fact that their cannabis product standards with regard to food safety and health was high and involved documentation of over 100 pages. . Setting Standards for Cannabis Research Studies . triggering new innovations and improved data quality through better user experiences.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Cannabis Law Report

JUNE 30, 2019

Lou Correa (D-CA) that would require the VA to conduct clinical trials on the therapeutic potential of cannabis in the treatment of such service-related conditions as post-traumatic stress disorder and chronic pain. Congress has asked vaporizer company JUUL for documents on any partnerships it may have with cannabis companies.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

SpeedWeed

DECEMBER 28, 2018

As first reported by Leafly, Altria has “over the past five years quietly patented dozens of devices that could be used to consume marijuana, a review of public documents at the US Patent and Trademark Office shows.” And then in December, Altria (formerly Phillip Morris) made a $1.8 ” Sen. Jim Dabakis (D-UT).

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. 2013 Sep;36(9):2530-5.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73